US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Curanex Pharmaceuticals

5.86

+0.26004.64%

Post-market: 5.74-0.1233-2.10%19:55 EDT

Volume:4.53M

Turnover:24.60M

Market Cap:162.62M

PE:-267.34

High:5.86

Open:5.42

Low:5.29

Close:5.60

52wk High:5.86

52wk Low:3.61

Shares:27.75M

Float Shares:3.75M

Volume Ratio:1.09

T/O Rate:120.72%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.0219

EPS(LYR):-0.0273

ROE:-196.72%

ROA:-28.92%

PB:444.70

PE(LYR):-214.94

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Curanex Pharmaceuticals Inc. Files Initial Beneficial Ownership Statement for COO Liqin Xie

Curanex Pharmaceuticals Inc. Announces Closing of its Initial Public Offering

Stock Track | Curanex Pharmaceuticals Plummets 9.75% Following IPO Pricing at $4.00 Per Share

Curanex Pharmaceuticals Prices $15 Million Initial Public Offering

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/CURX"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CURX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CURX\",,,,,undefined,":{"symbol":"CURX","market":"US","secType":"STK","nameCN":"Curanex Pharmaceuticals","latestPrice":5.86,"timestamp":1756843200000,"preClose":5.6,"halted":0,"volume":4527161,"hourTrading":{"tag":"盘后","latestPrice":5.7367,"preClose":5.86,"latestTime":"19:55 EDT","volume":9923,"amount":57200.2335,"timestamp":1756857301864},"delay":0,"floatShares":3750000,"shares":27750000,"eps":-0.02192,"marketStatus":"Not Yet Opened","change":0.26,"latestTime":"09-02 16:00:00 EDT","open":5.42,"high":5.86,"low":5.29,"amount":24603069.231067,"amplitude":0.101786,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.02192,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1756886400000},"marketStatusCode":0,"adr":0,"listingDate":1756180800000,"exchange":"NASDAQ","adjPreClose":5.6,"preHourTrading":{"tag":"盘前","latestPrice":5.43,"preClose":5.6,"latestTime":"09:27 EDT","volume":12746,"amount":70303.743127,"timestamp":1756819658049},"postHourTrading":{"tag":"盘后","latestPrice":5.7367,"preClose":5.86,"latestTime":"19:55 EDT","volume":9923,"amount":57200.2335,"timestamp":1756857301864},"volumeRatio":1.086777},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CURX\",,,,,undefined,":{"symbol":"CURX","floatShares":3750000,"roa":"-28.92%","roe":"-196.72%","lyrEps":-0.027264,"volumeRatio":1.086777,"shares":27750000,"dividePrice":0,"high":5.86,"amplitude":0.101786,"preClose":5.6,"low":5.29,"week52Low":3.61,"pbRate":"444.70","week52High":5.86,"institutionHeld":0,"latestPrice":5.86,"eps":-0.02192,"divideRate":0,"volume":4527161,"delay":0,"ttmEps":-0.02192,"open":5.42,"prevYearClose":4,"prevWeekClose":5.6,"prevMonthClose":5.6,"prevQuarterClose":4,"fiveDayClose":4,"twentyDayClose":4,"sixtyDayClose":4},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CURX\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CURX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CURX\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CURX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CURX","date":"2025-08-29","current":-343.821021,"percent":0,"low":-343.821021,"twenty":-323.7357,"median":-309.527845,"eighty":-285.033231,"high":-249.517771,"avg":-303.09862,"sd":33.960375,"marketCap":144022500},"quantilePoints":[{"date":"2025-08-29","current":-343.821021,"twenty":-323.7357,"median":-309.527845,"eighty":-285.033231,"marketCap":144022500}],"updateTime":1756846519384},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CURX\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2564332635","title":"Curanex Pharmaceuticals Inc. Files Initial Beneficial Ownership Statement for COO Liqin Xie","url":"https://stock-news.laohu8.com/highlight/detail?id=2564332635","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564332635?lang=en_us&edition=fundamental","pubTime":"2025-09-03 08:31","pubTimestamp":1756859482,"startTime":"0","endTime":"0","summary":"Curanex Pharmaceuticals Inc. has filed an initial statement of beneficial ownership. The filing identifies Xie Liqin as the beneficial owner, who serves as the Chief Operating Officer of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Curanex Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on September 02, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250903:nNDLbvgNW2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CURX","BK4007"],"gpt_icon":0},{"id":"2562778474","title":"Curanex Pharmaceuticals Inc. Announces Closing of its Initial Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2562778474","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562778474?lang=en_us&edition=fundamental","pubTime":"2025-08-28 05:00","pubTimestamp":1756328400,"startTime":"0","endTime":"0","summary":"Jericho, New York, Aug.  27, 2025  (GLOBE NEWSWIRE) -- Curanex Pharmaceuticals Inc. (Nasdaq: CURX) (\"Curanex\" or the \"Company\"), a developmental stage pharmaceutical company focused on discovering and","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/08/27/3140432/0/en/Curanex-Pharmaceuticals-Inc-Announces-Closing-of-its-Initial-Public-Offering.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CURX"],"gpt_icon":0},{"id":"1176815931","title":"Stock Track | Curanex Pharmaceuticals Plummets 9.75% Following IPO Pricing at $4.00 Per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=1176815931","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1176815931?lang=en_us&edition=fundamental","pubTime":"2025-08-26 22:46","pubTimestamp":1756219584,"startTime":"0","endTime":"0","summary":"Shares of Curanex Pharmaceuticals (NASDAQ: CURX) plummeted 9.75% in Tuesday's intraday trading session, following the announcement of its initial public offering (IPO) pricing. The developmental...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["CURX"],"gpt_icon":0},{"id":"2562373372","title":"Curanex Pharmaceuticals Prices $15 Million Initial Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2562373372","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562373372?lang=en_us&edition=fundamental","pubTime":"2025-08-26 19:55","pubTimestamp":1756209321,"startTime":"0","endTime":"0","summary":"Curanex Pharmaceuticals  said Tuesday it priced its initial public offering of 3.75 million common shares at $4 each, for gross proceeds of $15 million.IPO underwriters have a 45-day overallotment option to acquire up to 562,500 additional shares.The developmental-stage pharmaceutical company said it expects its shares to start trading on the Nasdaq Capital Market under the ticker symbol CURX Tuesday.It expects the IPO to close Wednesday and plans to use the proceeds for the development of its lead product candidate, Phyto-N, to treat ulcerative colitis, among other things.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CURX"],"gpt_icon":0}],"pageSize":4,"totalPage":2,"pageCount":1,"totalSize":8,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/CURX\",params:#limit:6,delay:false,,,undefined,":[]}}